… The purpose of this study is to develop consensus on key points that would support the use
of systemic bevacizumab for the treatment of recurrent respiratory papillomatosis (RRP), and …

… -onset recurrent respiratory papillomatosis (JORRP… consensus recommendations for the
evaluation and management of patients with juvenile-onset recurrent respiratory papillomatosis (…

… An international consensus statement on systemic Avastin has been prepared by Doug
Sidell and colleagues at Stanford University utilizing a Delphi method to address key point …

… An international consensus statement on systemic bevacizumab has been published to
guide clinicians and indicates that disease beyond the larynx is an appropriate criterion for …

… Recurrent respiratory papillomatosis (RRP) is a neoplastic … The results and statements
were presented at the RRP Task … The consensus statements were edited and approved by the …

… To this day, there is no cure for recurrent respiratory papillomatosis (RRP)… Consensus on
inclusion and exclusion was reached through discussion between the authors. If no consensus …

… Projected totals for adult recurrent respiratory papillomas were … The incidence of recurrent
respiratory papillomas among … No consensus was reached on the role for cesarean section. …

… Objective To evaluate how evolving treatment technologies have affected our management
of recurrent respiratory papilloma (RRP) since the last comprehensive survey of pediatric …

Objectives To identify studies evaluating the epidemiology of recurrent respiratory papillomatosis
(RRP), including patient demographics, human papillomavirus (HPV) immunology, …

… As of the most recent IPOG consensus statement, cidofovir is still utilized “sometimes” by
26% of respondents but has been largely supplanted by intralesional bevacizumab [15]. The …